Published in J Am Soc Nephrol on June 01, 1999
ANCA-associated vasculitides--advances in pathogenesis and treatment. Nat Rev Rheumatol (2010) 1.67
IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitis. Proc Natl Acad Sci U S A (2011) 1.61
Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis. J Clin Invest (2015) 1.43
Proteinase 3 is an IL-32 binding protein. Proc Natl Acad Sci U S A (2006) 1.32
The contribution of genetic variation and infection to the pathogenesis of ANCA-associated systemic vasculitis. Arthritis Res Ther (2010) 1.20
Annexin 1 cleavage in activated neutrophils: a pivotal role for proteinase 3. J Biol Chem (2007) 1.10
How anti-neutrophil cytoplasmic autoantibodies activate neutrophils. Clin Exp Immunol (2012) 1.07
Complement receptor Mac-1 is an adaptor for NB1 (CD177)-mediated PR3-ANCA neutrophil activation. J Biol Chem (2010) 1.07
Role of neutrophils in systemic autoimmune diseases. Arthritis Res Ther (2013) 1.05
Endothelium-neutrophil interactions in ANCA-associated diseases. J Am Soc Nephrol (2012) 1.02
Leukocyte cell surface proteinases: regulation of expression, functions, and mechanisms of surface localization. Int J Biochem Cell Biol (2008) 0.96
The human neutrophil subsets defined by the presence or absence of OLFM4 both transmigrate into tissue in vivo and give rise to distinct NETs in vitro. PLoS One (2013) 0.95
Interleukin 32 (IL-32) contains a typical α-helix bundle structure that resembles focal adhesion targeting region of focal adhesion kinase-1. J Biol Chem (2011) 0.94
Proteolysis of the endothelial cell protein C receptor by neutrophil proteinase 3. J Thromb Haemost (2007) 0.91
Neutrophil surface presentation of the anti-neutrophil cytoplasmic antibody-antigen proteinase 3 depends on N-terminal processing. Clin Exp Immunol (2008) 0.90
Neutrophils from vasculitis patients exhibit an increased propensity for activation by anti-neutrophil cytoplasmic antibodies. Clin Exp Immunol (2014) 0.86
Neutrophil-Derived Proteases in the Microenvironment of Pancreatic Cancer -Active Players in Tumor Progression. Int J Biol Sci (2016) 0.85
IL-32-PAR2 axis is an innate immunity sensor providing alternative signaling for LPS-TRIF axis. Sci Rep (2013) 0.85
The immunopathology of ANCA-associated vasculitis. Semin Immunopathol (2014) 0.83
The - 564 A/G polymorphism in the promoter region of the proteinase 3 gene associated with Wegener's granulomatosis does not increase the promoter activity. Clin Exp Immunol (2004) 0.82
Parietal and intravascular innate mechanisms of vascular inflammation. Arthritis Res Ther (2015) 0.82
Neutrophil proteinase 3 and dipeptidyl peptidase I (cathepsin C) as pharmacological targets in granulomatosis with polyangiitis (Wegener granulomatosis). Semin Immunopathol (2013) 0.82
Increased neutrophil membrane expression and plasma level of proteinase 3 in systemic vasculitis are not a consequence of the - 564 A/G promotor polymorphism. Clin Exp Immunol (2006) 0.81
Catalytic activity and inhibition of wegener antigen proteinase 3 on the cell surface of human polymorphonuclear neutrophils. J Biol Chem (2009) 0.81
Antineutrophil cytoplasmic antibody and vasculitis: much more than a disease marker. J Clin Invest (2002) 0.80
Differential expression of granulopoiesis related genes in neutrophil subsets distinguished by membrane expression of CD177. PLoS One (2014) 0.80
The use of small molecule high-throughput screening to identify inhibitors of the proteinase 3-NB1 interaction. Clin Exp Immunol (2010) 0.80
ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients. Nat Rev Rheumatol (2016) 0.80
Neutrophil Extracellular Traps in ANCA-Associated Vasculitis. Front Immunol (2016) 0.79
Standardised assessment of membrane proteinase 3 expression. Analysis in ANCA-associated vasculitis and controls. Ann Rheum Dis (2007) 0.78
Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Clin Epigenetics (2016) 0.76
A myelopoiesis gene signature during remission in anti-neutrophil cytoplasm antibody-associated vasculitis does not predict relapses but seems to reflect ongoing prednisolone therapy. Clin Exp Immunol (2014) 0.76
Pauci-Immune Crescentic Glomerulonephritis: An ANCA-Associated Vasculitis. Biomed Res Int (2015) 0.76
Proteinase 3 Is a Phosphatidylserine-binding Protein That Affects the Production and Function of Microvesicles. J Biol Chem (2016) 0.75
Pathogenesis of ANCA-associated vasculitis. Rheum Dis Clin North Am (2010) 0.75
[Wegener's granulomatosis and microscopic polyangiitis]. Z Rheumatol (2009) 0.75
Characterization of the CD177 interaction with the ANCA antigen proteinase 3. Sci Rep (2017) 0.75
Genetic Susceptibility to ANCA-Associated Vasculitis: State of the Art. Front Immunol (2014) 0.75
MicroRNA-941 Expression in Polymorphonuclear Granulocytes Is Not Related to Granulomatosis with Polyangiitis. PLoS One (2016) 0.75
Gene silencing and a novel monoallelic expression pattern in distinct CD177 neutrophil subsets. J Exp Med (2017) 0.75
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum (2013) 11.18
EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis (2008) 4.88
Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int (1998) 4.31
Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis (2004) 3.95
Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum (2001) 3.67
A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum (1997) 3.62
Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest (2000) 3.60
Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum (2004) 3.46
Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry. Arthritis Rheum (2009) 2.92
Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) (1996) 2.72
Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state. Ann Rheum Dis (2004) 2.60
Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet (1997) 2.38
Randomized, prospective, placebo-controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosis. Arthritis Rheum (2010) 2.37
Implementation of the Ottawa ankle rules in France. A multicenter randomized controlled trial. JAMA (1997) 2.34
A clinical decision support system for prevention of venous thromboembolism: effect on physician behavior. JAMA (2000) 2.34
Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int (1999) 2.26
EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis (2008) 2.25
CFTR biomarkers: time for promotion to surrogate end-point. Eur Respir J (2012) 2.11
Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann Rheum Dis (2004) 2.06
A new method to test genetic models in HLA associated diseases: the MASC method. Ann Hum Genet (1988) 2.03
BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology (Oxford) (2007) 2.02
Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force. Ann Rheum Dis (2007) 2.01
Pregnancy outcome and weight gain recommendations for the morbidly obese woman. Obstet Gynecol (1998) 2.00
Management of nontuberculous infectious discitis. treatments used in 110 patients admitted to 12 teaching hospitals in France. Joint Bone Spine (2001) 1.98
Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients. Rheumatology (Oxford) (2002) 1.96
Longer duration of predialysis nephrological care is associated with improved long-term survival of dialysis patients. Nephrol Dial Transplant (2001) 1.90
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis (2007) 1.90
High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis. Arthritis Rheum (2008) 1.90
Antibiotic treatment of Yersinia enterocolitica septicemia: a retrospective review of 43 cases. Clin Infect Dis (1993) 1.88
The value of indirect immunofluorescence and solid phase techniques for ANCA detection. A report on the first phase of an international cooperative study on the standardization of ANCA assays. EEC/BCR Group for ANCA Assay Standardization. J Immunol Methods (1993) 1.86
Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome--62 patients. J Rheumatol (1993) 1.86
A note on allelic tests in case-control association studies. Ann Hum Genet (2008) 1.86
Diabetes mellitus after abdominal radiation therapy. Lancet (1995) 1.79
Maternally inherited diabetes and deafness: a multicenter study. Ann Intern Med (2001) 1.75
Haemophilus endocarditis: report of 42 cases in adults and review. Haemophilus Endocarditis Study Group. Clin Infect Dis (1997) 1.75
Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies. Kidney Int (2006) 1.74
Inefficacy and toxicity of pefloxacin in focal and segmental glomerulosclerosis with steroid-resistant nephrotic syndrome. Lancet (1993) 1.72
Infective endocarditis in Europe: lessons from the Euro heart survey. Heart (2005) 1.70
A proteome analysis of the cadmium response in Saccharomyces cerevisiae. J Biol Chem (2000) 1.68
An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness. Proc Natl Acad Sci U S A (2000) 1.68
Liver involvement in autosomal-dominant polycystic kidney disease: therapeutic dilemma. J Am Soc Nephrol (2000) 1.66
Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial. Br J Anaesth (2011) 1.65
Expression of the L-type pyruvate kinase gene and the hepatocyte nuclear factor 4 transcription factor in exocrine and endocrine pancreas. J Biol Chem (1994) 1.64
Cryoglobulinemia with vasculitis associated with hepatitis C virus infection. Gastroenterology (1993) 1.64
Pulmonary Wegener's granulomatosis. A clinical and imaging study of 77 cases. Chest (1990) 1.64
Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. J Clin Invest (1992) 1.63
Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry. Ann Rheum Dis (2010) 1.59
Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. Kidney Int (1993) 1.56
Early renal changes in hemizygous and heterozygous patients with Fabry's disease. Kidney Int (1978) 1.56
H deficiency in two brothers with atypical dense intramembranous deposit disease. Kidney Int (1986) 1.55
Genetic heterogeneity of Alport syndrome. Kidney Int (1985) 1.55
A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis. Neurology (1997) 1.54
Streptococcus pneumoniae endocarditis in adults. A multicenter study in France in the era of penicillin resistance (1991-1998). The Pneumococcal Endocarditis Study Group. Medicine (Baltimore) (2000) 1.50
Exceptional motifs in different Markov chain models for a statistical analysis of DNA sequences. J Comput Biol (1995) 1.50
Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease. J Rheumatol (2001) 1.49
Renal prognosis in Alport's and related syndromes: influence of the mode of inheritance. Nephrol Dial Transplant (1989) 1.48
Necrotizing crescentic glomerulonephritis without significant immune deposits: a clinical and serological study. Q J Med (1993) 1.48
Collagen alpha5 and alpha2(IV) chain coexpression: analysis of skin biopsies of Alport patients. Kidney Int (2007) 1.48
Clinical and ultrasonographic predictors of joint replacement for knee osteoarthritis: results from a large, 3-year, prospective EULAR study. Ann Rheum Dis (2009) 1.47
Gitelman syndrome comes of age. Nephrol Dial Transplant (1998) 1.47
Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry. Arthritis Rheum (2010) 1.47
Vasculitides secondary to infections. Clin Exp Rheumatol (2006) 1.47
Autosomal dominant polycystic kidney disease with primary hyperaldosteronism. Nephrol Dial Transplant (1992) 1.46
Virus-associated vasculitides. Rheumatology (Oxford) (1999) 1.45
Distribution of prostaglandins in inflammatory exudate. J Pathol (1973) 1.45
EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 1: prevalence of inflammation in osteoarthritis. Ann Rheum Dis (2005) 1.44
Progress in systemic sclerosis: a 10-year perspective. Rheumatology (Oxford) (2009) 1.44
The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol (1999) 1.44
Inverse complementary homologues of short cysteine signatures. C R Acad Sci III (2000) 1.42
Resistance of Streptococcus pneumoniae to deformylase inhibitors is due to mutations in defB. Antimicrob Agents Chemother (2001) 1.41
Fear-avoidance beliefs about back pain in patients with subacute low back pain. Pain (2006) 1.41
Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multinational study. Arthritis Care Res (Hoboken) (2012) 1.40
Cyclosporin A does not delay insulin dependency in asymptomatic IDDM patients. Diabetes Care (1995) 1.40
Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families. Diabetologia (1997) 1.40
Acute renal failure in pregnancy. Baillieres Clin Obstet Gynaecol (1994) 1.39
A prescription for healing the system. Pa Med (1996) 1.39
Bone densitometry in patients with multiple myeloma. Am J Med (1992) 1.38
Neutrophil polarity and locomotion are associated with surface redistribution of leukosialin (CD43), an antiadhesive membrane molecule. Blood (2000) 1.38
Knowledge, attitudes and vaccination coverage of healthcare workers regarding occupational vaccinations. Vaccine (2009) 1.38
Medication misuse in hospitalized patients with renal impairment. Int J Qual Health Care (2003) 1.38
Sclerochoroidal calcification associated with Gitelman syndrome. Am J Ophthalmol (1999) 1.38
Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases. J Rheumatol (1994) 1.37
Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis. Kidney Int (2006) 1.37
The spectrum of vasculitis in human immunodeficiency virus-infected patients. A clinicopathologic evaluation. Arthritis Rheum (1993) 1.36
The leucotriene receptor antagonist montelukast and the risk of Churg-Strauss syndrome: a case-crossover study. Thorax (2008) 1.35
Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients. Ann Rheum Dis (2007) 1.35
Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine (Baltimore) (1995) 1.35
Impact of reminders and method of questionnaire distribution on patient response to mail-back satisfaction survey. J Clin Epidemiol (2001) 1.35
Charge and size of mesangial IgA in IgA nephropathy. Kidney Int (1985) 1.34
The clinical spectrum of hereditary nephritis. Kidney Int (1985) 1.33
Cryptogenetic multifocal ulcerous stenosing enteritis: an atypical type of vasculitis or a disease mimicking vasculitis. Gut (2001) 1.32
Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry. Ann Rheum Dis (2009) 1.30
European consensus statement on the terminology used in the management of lupus glomerulonephritis. Lupus (2009) 1.28